BioMarin Pharmaceutical Inc. (BMRN) Reports Q1 Loss of $0.04
Tweet
Share
E-mailGet Alerts BMRN Hot Sheet
Price: $58.71 -0.47%
EPS Growth %: -34.0%
Financial Fact:
Royalty and license revenues: 1.63M
Today's EPS Names:
CRMT, PKE, More
EPS Growth %: -34.0%
Financial Fact:
Royalty and license revenues: 1.63M
Today's EPS Names:
CRMT, PKE, More
Join SI Premium – FREE
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) reported Q1 EPS of ($0.04), $0.06 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $109.46 million versus the consensus estimate of $103.8 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Greenbrier Cos. (GBX) Reports In-Line Q3 EPS
- Concentrix Corporation (CNXC) Misses Q2 EPS by 1c; Guides lower than expectations
- Constellation Brands (STZ) Tops Q1 EPS by 18c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
